The emerging roles of Rad51 in cancer and its potential as a therapeutic target

Z Wang, R Jia, L Wang, Q Yang, X Hu, Q Fu… - Frontiers in …, 2022 - frontiersin.org
Defects in DNA repair pathways are emerging hallmarks of cancer. Accurate DNA repairs
and replications are essential for genomic stability. Cancer cells require residual DNA repair …

Overcoming the impact of hypoxia in driving radiotherapy resistance in head and neck squamous cell carcinoma

RM Hill, S Rocha, JL Parsons - Cancers, 2022 - mdpi.com
Simple Summary Hypoxia (reduced oxygen availability) is common in the majority of
tumours, including head and neck cancer, and it occurs due to an imbalance between …

Recent advances in the development of non-PIKKs targeting small molecule inhibitors of DNA double-strand break repair

JM Kelm, A Samarbakhsh, A Pillai… - Frontiers in …, 2022 - frontiersin.org
The vast majority of cancer patients receive DNA-damaging drugs or ionizing radiation (IR)
during their course of treatment, yet the efficacy of these therapies is tempered by DNA …

[HTML][HTML] Utilization of DNA double-strand breaks for biodosimetry of ionizing radiation exposure

A Bushmanov, N Vorobyeva, D Molodtsova… - Environmental …, 2022 - Elsevier
Abstract Analysis of DNA double-strand breaks (DSBs) is an important novel tool to estimate
the biological effects of ionizing radiation. Despite the large number of developed methods …

The PARP1 inhibitor niraparib represses DNA damage repair and synergizes with temozolomide for antimyeloma effects

HY Shen, HL Tang, YH Zheng, J Feng… - Journal of …, 2022 - Wiley Online Library
Purpose. Poly (ADP‐ribose) polymerase 1 (PARP1) is necessary for single‐strand break
(SSB) repair by sensing DNA breaks and facilitating DNA repair through poly ADP …

PAK6 promotes homologous-recombination to enhance chemoresistance to oxaliplatin through ATR/CHK1 signaling in gastric cancer

W Huang, Z Han, Z Sun, H Feng, L Zhao, Q Yuan… - Cell Death & …, 2022 - nature.com
Chemoresistance remains the primary challenge of clinical treatment of gastric cancer (GC),
making the biomarkers of chemoresistance crucial for treatment decision. Our previous study …

The fellowship of the RING: BRCA1, its partner BARD1 and their liaison in DNA repair and cancer

M Russi, D Marson, A Fermeglia, S Aulic… - Pharmacology & …, 2022 - Elsevier
The breast cancer type 1 susceptibility protein (BRCA1) and its partner–the BRCA1-
associated RING domain protein 1 (BARD1)–are key players in a plethora of fundamental …

Fanconi anemia pathway in colorectal cancer: A novel opportunity for diagnosis, prognosis and therapy

FG Parsa, S Nobili, M Karimpour, HA Aghdaei… - Journal of Personalized …, 2022 - mdpi.com
Colorectal cancer (CRC) is the third most commonly diagnosed malignancy and has the
second highest mortality rate globally. Thanks to the advent of next-generation sequencing …

Tissue-based markers as a tool to assess response to neoadjuvant radiotherapy in rectal cancer—systematic review

E Smolskas, G Mikulskytė, E Sileika… - International journal of …, 2022 - mdpi.com
According to current guidelines, the current treatment for locally advanced rectal cancer is
neoadjuvant therapy, followed by a total mesorectal excision. However, radiosensitivity …

A Pan‐Cancer Analysis of the Oncogenic Roles of RAD51 in Human Tumors

H Lu, Z Li, L Liu, Y Tao, Y Zhou, X Mao… - Advanced Gut & …, 2022 - Wiley Online Library
Objective. RAD51 homolog 1 (RAD51) plays significant roles in DNA damage repair and
apoptosis. These pathways are tightly associated with tumor initiation and progression. To …